Invenomic Capital Management LP Quidel Ortho Corp Transaction History

Invenomic Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$58.16 - $75.44 $29.3 Million - $38 Million	503,991 New	503,991 $37.1 Million
Q2 2023 Aug 14, 2023	SELL	$81.09 - $94.16 $41,031 - $47,644	-506 Reduced 1.31%	38,218 $3.17 Million
Q1 2023 May 15, 2023	BUY	$82.98 - $91.46 $73,935 - $81,490	891 Added 2.36%	38,724 $3.45 Million
Q4 2022 Feb 14, 2023	BUY	$66.93 - $97.5 $1.63 Million - $2.38 Million	24,363 Added 180.87%	37,833 $3.24 Million
Q3 2022 Nov 14, 2022	BUY	$69.86 - $107.63 $941,014 - $1.45 Million	13,470 New	13,470 $963,000

293

67.9M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.69B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Invenomic Capital Management LP with notifications on news.